ADAR1 Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,750
| Closed | -$3.67M | – | 203 |
|
|
2025
Q1 | $3.67M | Buy |
41,750
+15,235
| +57% | +$1.34M | 0.68% | 40 |
|
|
2024
Q4 | $2.46M | Buy |
26,515
+23,284
| +721% | +$2.16M | 0.49% | 42 |
|
|
2024
Q3 | $236K | Sell |
3,231
-3,824
| -54% | -$280K | 0.04% | 144 |
|
|
2024
Q2 | $410K | Buy |
7,055
+6,601
| +1,454% | +$384K | 0.08% | 101 |
|
|
2024
Q1 | $470K | Buy |
+454
| New | +$470K | 0.11% | 80 |
|